Top Markets
#1 ADO Protocol ADO Protocol +337.14%
#2 GoPlus Security GoPlus Security +57.08%
#3 Tutorial Tutorial +43.54%
#4 Nockchain Nockchain +38.56%
#5 Starpower Starpower +38.12%
#6 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +25.07%
#7 GAIB AID GAIB AID +24.67%
#8 The Black Bull The Black Bull +23.13%
#9 OpenEden OpenEden +15.63%
#10 Casper Network Casper Network +14.56%
Coin of the day
ADO Protocol ADO Protocol
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Traws Pharma, Inc. Traws Pharma, Inc.

Traws Pharma, Inc.

TRAW
Classement en actions #33205
Traws Pharma, Inc., a biopharmaceutical firm in the clinical development stage,... Traws Pharma, Inc., a biopharmaceutical firm in the clinical development stage, is dedicated to creating novel small-molecule medications delivered orally to combat both respiratory viral infections and various forms of cancer. Its pipeline includes experimental treatments specifically designed to overcome drug resistance in influenza and COVID-19. These promising candidates include TRX01 (travatrelvir), an Mpro/3CL inhibitor currently undergoing development for COVID-19, and TRX100 (viroxavir), an endonuclease inhibitor advancing through trials for pandemic influenza. Additionally, Traws Pharma's oncology portfolio features narazaciclib, a multi-kinase CDK4/6 inhibitor. This compound is presently in Phase 1/2 clinical trials in cancer patients, being evaluated both independently and in conjunction with letrozole, with the goal of establishing the recommended Phase 2 dosage for future work in endometrial cancer. The company is also investigating oral rigosertib, exploring its potential as a standalone therapy or in combination regimens across diverse cancer types. Originally established in 1998 as Onconova Therapeutics, Inc., the company officially adopted its current name, Traws Pharma, Inc., in April 2024. Its corporate headquarters are located in Newtown, Pennsylvania.
Prix de l'action
$0.54
Capitalisation boursière
$8.22M
Changement (1 jour)
-5.43%
Changement (1 an)
-64.24%
Pays
US
Échange Traws Pharma, Inc. (TRAW)

Catégorie

Healthcare
Historique du prix de l'action pour Traws Pharma, Inc. (TRAW)
Prix de clôture le plus élevé : $0.55 le 2026-08-01

Prix de clôture le plus bas : $1.18M le 2013-07-01
Historique du prix de l'action de Traws Pharma, Inc. de 2013 à 2026
Performance annuelle du prix de l'action
Année Performance
2026 (TTM) -7.87%
2025 -73.19%
2024 -62.45%
2023 -1.12%
2022 -73.33%
2021 -51.96%
2020 16.11%
2019 -88.57%
2018 -87.09%
2017 -39.73%
2016 -78.39%
2015 -71.56%
2014 -71.82%
2013 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $513.73 30.79%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $993.55 51.96%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $736.64 7.19%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $255.50 13.38%
BE